DK0957920T3 - Reduktion af carboplatins toksiske effekt under anvendelse af dithioethere - Google Patents
Reduktion af carboplatins toksiske effekt under anvendelse af dithioethereInfo
- Publication number
- DK0957920T3 DK0957920T3 DK97941110T DK97941110T DK0957920T3 DK 0957920 T3 DK0957920 T3 DK 0957920T3 DK 97941110 T DK97941110 T DK 97941110T DK 97941110 T DK97941110 T DK 97941110T DK 0957920 T3 DK0957920 T3 DK 0957920T3
- Authority
- DK
- Denmark
- Prior art keywords
- carboplatin
- toxic effect
- dithioether
- dithioethers
- reduction
- Prior art date
Links
- 229960004562 carboplatin Drugs 0.000 title abstract 5
- 231100000331 toxic Toxicity 0.000 title abstract 2
- 230000002588 toxic effect Effects 0.000 title abstract 2
- 190000008236 carboplatin Chemical compound 0.000 title 1
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 abstract 4
- KQYGMURBTJPBPQ-UHFFFAOYSA-L disodium;2-(2-sulfonatoethyldisulfanyl)ethanesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)CCSSCCS([O-])(=O)=O KQYGMURBTJPBPQ-UHFFFAOYSA-L 0.000 abstract 2
- 206010065553 Bone marrow failure Diseases 0.000 abstract 1
- 229910018828 PO3H2 Inorganic materials 0.000 abstract 1
- 229910006069 SO3H Inorganic materials 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229950009278 dimesna Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2643096P | 1996-09-23 | 1996-09-23 | |
| PCT/GB1997/002582 WO1998011898A1 (en) | 1996-09-23 | 1997-09-23 | Reducing toxic effects of carboplatin using dithioethers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0957920T3 true DK0957920T3 (da) | 2002-04-02 |
Family
ID=21831779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97941110T DK0957920T3 (da) | 1996-09-23 | 1997-09-23 | Reduktion af carboplatins toksiske effekt under anvendelse af dithioethere |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0957920B1 (da) |
| JP (3) | JP2001500872A (da) |
| CN (1) | CN1129432C (da) |
| AT (1) | ATE210987T1 (da) |
| AU (1) | AU712548B2 (da) |
| CA (1) | CA2263166C (da) |
| DE (1) | DE69709404T2 (da) |
| DK (1) | DK0957920T3 (da) |
| ES (1) | ES2170414T3 (da) |
| PT (1) | PT957920E (da) |
| WO (1) | WO1998011898A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6177411B1 (en) * | 1999-02-09 | 2001-01-23 | Bionumerik Pharmaceuticals, Inc. | Method for treating heavy metal poisoning |
| KR20030014208A (ko) | 2000-04-26 | 2003-02-15 | 오레곤 헬스 사이언시즈 유니버시티 | 티올계 화학보호제 화합물의 투여 |
| WO2002056755A2 (en) * | 2001-01-19 | 2002-07-25 | Bionumerik Pharmaceuticals, Inc. | Method for treating cancer |
| US8710095B2 (en) | 2002-04-30 | 2014-04-29 | Bionumerik Pharmaceuticals, Inc. | Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity |
| US7282602B2 (en) * | 2004-09-21 | 2007-10-16 | Bionumerik Pharmaceuticals, Inc. | Medicinal disulfide salts |
| DK2249825T3 (da) * | 2008-03-14 | 2016-01-11 | Bionumerik Pharmaceuticals Inc | Behandlingsmetoder og sammensætninger til lungecancer, adenocarcinom og andre medicinske tilstande |
| CN111632146B (zh) * | 2020-05-29 | 2021-09-28 | 中山大学 | Oat抑制剂和溶瘤病毒在制备抗肿瘤药物中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5789000A (en) * | 1994-11-14 | 1998-08-04 | Bionumerik Pharmaceuticals, Inc. | Sterile aqueous parenteral formulations of cis-diammine dichloro platinum |
-
1997
- 1997-09-23 DK DK97941110T patent/DK0957920T3/da active
- 1997-09-23 WO PCT/GB1997/002582 patent/WO1998011898A1/en not_active Ceased
- 1997-09-23 AT AT97941110T patent/ATE210987T1/de active
- 1997-09-23 EP EP97941110A patent/EP0957920B1/en not_active Expired - Lifetime
- 1997-09-23 CA CA002263166A patent/CA2263166C/en not_active Expired - Fee Related
- 1997-09-23 PT PT97941110T patent/PT957920E/pt unknown
- 1997-09-23 AU AU43133/97A patent/AU712548B2/en not_active Ceased
- 1997-09-23 DE DE69709404T patent/DE69709404T2/de not_active Expired - Lifetime
- 1997-09-23 JP JP10514414A patent/JP2001500872A/ja active Pending
- 1997-09-23 ES ES97941110T patent/ES2170414T3/es not_active Expired - Lifetime
- 1997-09-23 CN CN97198132A patent/CN1129432C/zh not_active Expired - Fee Related
-
2009
- 2009-02-12 JP JP2009030370A patent/JP2009143950A/ja active Pending
-
2013
- 2013-05-16 JP JP2013103975A patent/JP2013155200A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATE210987T1 (de) | 2002-01-15 |
| JP2013155200A (ja) | 2013-08-15 |
| WO1998011898A1 (en) | 1998-03-26 |
| CA2263166C (en) | 2006-12-12 |
| JP2009143950A (ja) | 2009-07-02 |
| ES2170414T3 (es) | 2002-08-01 |
| DE69709404D1 (de) | 2002-01-31 |
| EP0957920B1 (en) | 2001-12-19 |
| AU4313397A (en) | 1998-04-14 |
| PT957920E (pt) | 2002-06-28 |
| DE69709404T2 (de) | 2002-05-29 |
| CN1230887A (zh) | 1999-10-06 |
| AU712548B2 (en) | 1999-11-11 |
| EP0957920A1 (en) | 1999-11-24 |
| JP2001500872A (ja) | 2001-01-23 |
| CA2263166A1 (en) | 1998-03-26 |
| CN1129432C (zh) | 2003-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0792154T3 (da) | Sammensætning af cisplatin i kombination med 2,2'-dithio-bis(ethansulfonat) (dimesna) | |
| BR9807814A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos de tratamento e para preparação de um composto | |
| ES2127397T3 (es) | Sulfonamidas y sus derivados que modulan la actividad de la endotelina. | |
| ES2126068T3 (es) | Derivados de estilbeno citotoxicos y composicion farmaceutica que los contiene. | |
| KR890011902A (ko) | 디데옥시디데히드로카르보시클릭 뉴클레오시드 | |
| KR890016966A (ko) | 신규 항바이러스제 | |
| DE69931159D1 (de) | Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat | |
| DE69503647D1 (de) | Aminoheterocyclische derivate als antithrombotische oder antikoagulierende mittel | |
| FR11C0038I2 (fr) | Analogues macrocycliques, leurs procedes d'utilisation et de preparation | |
| DE122005000058I1 (de) | Depsipeptide, Herstellung und Anwendung | |
| NZ334550A (en) | Use of sibutramine analogues to lower lipid levels | |
| RU99112577A (ru) | Новое применение 1,3-пропандиольных производных | |
| DE68901153D1 (de) | Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung. | |
| ES2142773A1 (es) | Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida. | |
| CA2250861A1 (en) | Cyclic adhesion inhibitors | |
| ES2170414T3 (es) | Reduccion de efectos toxicos del carboplatino usando ditioeteres. | |
| ATE150301T1 (de) | Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen | |
| KR900016238A (ko) | 신규 화합물 | |
| AR010809A1 (es) | Compuestos derivados de aminofosfonatos, un procedimiento para su preparacion, composicion farmaceutica que los comprenden, uso de los mismospara la fabricacion de un medicamento util en el tratamiento de arterioesclerosis | |
| ES2185153T3 (es) | Uso de mefloquina(+) para el tratamiento de la malaria. | |
| AR007052A1 (es) | Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende | |
| KR950701638A (ko) | 푸린 동족체의 항비루스성 포스폰산 유도체(Antiviral phosphonic acid derivatives of purine analogues) | |
| TR199700735T1 (xx) | �ste�e g�re azt,DD1 ya da DDC ile birlikte ters transkritaz inhibit�r� 3T ve HIV proteaz inhibit�r� indinavirin kullan�lmas�yla HIV enfeksiyoun i�in bir arada terapi. | |
| FI895012A0 (fi) | Laekemedel innehaollande nitroxialkylaminer med amidfunktion samt foerfarande foer framstaellning av naemnda foereningar. | |
| NO944241D0 (no) | Fremstilling og anvendelse av sykliske heksapeptider |